Previously added items:
GE Healthcare has reached an agreement to sell its Dharmacon business to Horizon Discovery, a world leader in gene editing applications for pharma, biotech and research labs.
We anticipate the deal to complete in August. We remain focused on supporting and serving our customers while the agreement is completed. Please contact your commercial representative if you have any questions.
Our RNAi products encompass the most complete portfolio of innovative tools for transient, long-term, inducible and in vivo RNAi applications.
Interrogate gene function through targeted genome editing using powerful molecular tools to permanently alter endogenous gene expression.
cDNAs and ORFs can be used to overexpress particular genes of interest. Choose from individual clones, lentiviral ORFs, and genome-scale libraries.
Use our online design tools and extensive synthesis options to create custom products specific to your application.
A comprehensive portfolio of competitively priced, proven transfection reagents for a wide range of applications.
The safest and most effective strategy for packaging virus to efficiently express your shRNA or gene of interest.
Dharmacon BioIT beta tools page implements cutting-edge tools, allowing for efficient data analysis and empowering scientific researchers. Try the tools out now!
Does your microscope have what it takes?
The right microscope matters when verifying localization of fluorescence from HDR-mediated knock-in experiments.
Your cell line & target protein impact the success of fluorescent knock-in with HDR. Here’s what you need to know!